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Conclusions: ICVO is a frequent and under-appreciated contributor
to venous hypertension in patients with venous leg ulcers. Patients with a
history of DVT or duplex-diagnosed DVR have a higher incidence of
outflow obstruction and should be routinely studied with CT or MR
venography to allow correction in this high-risk group of patients.
Table. Incidence of iliocaval stenosis in all cases and in
limbs with prior deep vein thrombosis (DVT) or deep
venous reflux (DVR)
Iliocaval stenosis Total cases, % DVT history, % DVR, %
100% 8.8 17.2 18.3
80% to 99% 14 20.7 21.5
50% to 79% 14 13.8 12.3
30% to 49% 5.3 3.4 5.1
10% to 29% 17.5 13.8 11.8
10% 42.1 31 30.8
Stenting for Iliac Veins Post-thrombotic Obstructive Lesions: Results
of a Multicentric Retrospective Study
O. Hartung,a M. Lugli,b P. Nicolini,c M. Boufi,a O. Maleti,b and
Y. S. Alimi,a Marseille and Lyon, France; and Modena, Italy
From CHU Nord, Marseillea; Hesperia Hospital, Modenab; and Clinique
du Grand Large, Lyon.c
Background: Stenting was recognized as the method of choice for
treatment of femoroiliac veins obstructive disease. We report the experience
of three European centers in the endovascular treatment of post-thrombotic
obstructive lesions, which are recognized as the most challenging.
Methods: From January 1996 to July 2009, 130 limbs in 109 consec-
utive patients (66 women; median age, 44 years; thrombophilia, 28 patients)
were admitted for endovascular treatment of nonmalignant post-deep vein
thrombosis (DVT) iliac veins obstructive disease. Limbs were classified
CEAP C1 in 1 limb, C2 in 1, C3 in 42, C4 in 28, C5 in 11, and C6 in 47. All
patients were symptomatic and disabled despite medical treatment, includ-
ing 49 with venous claudication. Median delay since DVT was 12 years.
Lesions were bilateral in 21 patients. The inferior vena cava (IVC) was
involved in 21 cases and the common femoral vein in 33; moreover, 80 limbs
(61%) had at least one occluded venous segment. Four IVC filters and two
IVC clips were in place. The endovascular procedure was performed through
percutaneous access of the femoral vein. Recanalization was performedwhen
needed; then, self-expanding stents were deployed.
Results: Sixty-three patients had general anesthesia, and 46 had local
anesthesia, associated with sedation in 44 cases. Recanalization failed in 22
limbs (15 patients), and the procedure was stopped. Moreover, recanaliza-
tion failed in three limbs, but the ipsilateral ascending lumbar vein was
stented. A total of 181 stents were deployed to treat 149 venous segments.
One IVC clip was removed. No perioperative death or pulmonary embolism
occurred. One superficial femoral artery tear was treated with a stent graft.
Postoperative complications included four early rethrombosis (3 had left
iliac vein recanalization with common femoral vein involvement and 3 were
successfully treated by venous thrombectomy), one right hemothorax, and
two hematomas. Median length of stay was 3 days (range, 1-14 days).
During a median 27 months’ follow-up (range, 1-157 months), one patient
died at 18 months, four symptomatic restenosis needed iterative endovas-
cular procedure, and five late rethrombosis were diagnosed (2 had successful
venous thrombectomy). Moreover, one patient with contralateral femo-
roiliac DVT was successfully treated by venous thrombectomy. Primary,
assisted primary, and secondary patency rates in intention to treat were,
respectively, 76%, 77%, and 80% at 1 year, and 66%, 70%, and 77% at 5 and
10 years (90%, 91%, and 93% at 1 year, and 77%, 82%, and 86% at 10 years
in case of technical success). All C6 limbs but two had healed at the end of the
follow-up.
Conclusions: Late results confirm that stenting is a safe and effective
technique. It is also a durable way to treat post-thrombotic obstructive
disease in iliac veins.
The Efficacy of NewVEINOPLUS Stimulation Technology to Increase
Venous Flow and Prevent Venous Stasis
M. B. Griffin,a A. N. Nicolaides,a D. Bond,a G. Geroulakos,b and
E. Kalodiki,b London, United Kingdom
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Background: Electrostimulation of calf muscles has been shown to be
effective in prevention of deep venous thrombosis (DVT). Nevertheless, the
stimulation rates needed to obtain optimal hemodynamic effects for prevent-
ing venous stasis have not yet been investigated. The goal of this study was
to determine (1) dependence of venous blood velocity and ejected volume
on the rates of stimulated calf contractions and (2) clinical factors that affect
efficacy.
Methods: The maximum intensity stimulus that can be tolerated
comfortably was applied to calves of 12 healthy volunteers. In popliteal
veins, peak velocities (PV) and total volume flow (TVF) of expelled blood
were determined using duplex Doppler imaging. Eleven stimulation rates: 2,
3, 4, 6, 7.5, 10, 15, 20, 30, 60, and 120 beats/min were applied using Food
and Drug Administration- and Conformite´ Europe´ene-registered VEINO-
PLUS devices.
Results: PV decreased and TVF increased with increasing rate of
stimulation. The mean and 95% confidence interval of the PV and TVF
measurements obtained at 5, 60 and 120 beats/min are shown in the Fig.
The rates of stimulation resulting in highest mean TVF were 60 and 120
beats/min. They showed an increase of TVF equal to 7 times baseline. In
addition, there were simultaneous increases of mean PV equal to 5 times
baseline at a rate of 60 and 4 times baseline at a rate of 120. The stimulation
rate of 5 beats/min produced highest mean PV of 11 times baseline yet
resulted in only a small increase of mean TVF (2 times baseline). The PV
and TVF were approximately 40% lower in women and were 30% lower in
volunteers aged older than50 years, those with calf circumference37cm,
and/or in those with popliteal vein diameter 0.87cm. Logistic regression
with PV as the dependent variable found the following clinical factors
remained significant: rate (P  .001), age (P  .001), gender (P  .001),
calf circumference (P  .003), and popliteal vein lumen diameter (P 
.005).
Conclusions: VEINOPLUS stimulation is an effective method of
activating the calf muscle pump. The enhancements of popliteal blood
velocity and volume flow, as shown by this study, are key factors in the
prevention of venous stasis and DVT. Further studies are justified to deter-
mine the rates and configurations of stimulation, which are applicable in
presence or absence of clinical factors and venous reflux, which influence calf
pump output.
Period Prevalence of Iliofemoral Venous Occlusive Disease by Doppler
Ultrasound Imaging and Corresponding Treatment in a Tertiary Care
Facility
P. R. Crisostomo, J. Cho, B. Feliciano, J. Klein, D. Jones, and
M. C. Dalsing, Indianapolis, Ind
From Indiana University.
Background: Patients with iliofemoral deep venous thrombosis
(DVT) are at highest risk for post-thrombotic morbidity, including the
post-thrombotic syndrome. Invasive therapies such as catheter-directed
thrombolysis (CDL), thrombectomy with or without balloon angioplasty,
and stenting improves venous patency, venous valve function, and quality of
life in patients with acute iliofemoral DVT.What is the current prevalence of
acute iliofemoral DVT and how aggressively is it being treated? We hypoth-
esized that the 10-year period prevalence of iliofemoral DVT among acute
DVT cases is greater than previously reported and that thrombus removal to
treat acute iliofemoral DVT is little utilized in current practice.
Methods: Indiana University (IU) vascular laboratory records from
January 1, 1998, to December 31, 2008, were searched by Current Proce-
dural Terminology code for venous Doppler ultrasound study (n  7240).
A random sample of 750 patients based on the number in IUmedical record
of lower extremity Doppler studies was then selected for retrospective record
review. Corresponding clinical information was gathered from the patients’
electronic medical record in Cerner PowerChart.
Fig. Peak velocity (PV) and total volume flow (TVF) vs rate of
stimulation.
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Results: Acute DVT occurred in 7.3%, and chronic DVT occurred in
9.7% of patients studied (24.0% inpatients, 60.9% female; mean age, 56.3
years [range, 4-91 years, 1.1% aged 16 years]). History of previous DVT
(74.0%) and smoking (38.0%) were the most common risk factors in patients
with DVT. Iliac DVT was identified in 9.6% of acute DVT and in 5.7% of
chronic DVT. Common femoral DVT was identified in 30.8% of acute DVT
and in 22.9% of chronic DVT. CDL was used in 14.3% and thrombectomy
in 4.8% of acute iliac/common femoral DVT and was never used with distal
DVT.Warfarin anticoagulation with or without heparin/enoxaparin overlap
was the most common treatment for acute (58.5%) and chronic (48.6%)
iliac/common femoral DVT. In 2008 the referral base of the IU laboratory
increased significantly. Acute DVT occurred significantly less often during
the 1-year period of 2008 (5.3%) than in the 10-year period 1998 to 2007
(7.6%), but iliac/common femoral DVT as a component of acute DVT did
not differ significantly (40.0% in 2008, 41.9% in 1998-2007).
Conclusions: Iliac/common femoral DVT affects almost half of pa-
tients with acute DVT. Current recommendations of acute thrombus re-
moval for the treatment of iliofemoral DVT is under-utilized, suggesting
that perhaps greater education of clinicians and patients regarding invasive
therapy for iliofemoral DVT is necessary.
Incidence of Varicose Veins, Chronic Venous Insufficiency, and Progres-
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Background: Chronic venous disorders (CVD) are among the most
common diseases in Germany. In the Bonn Vein Study I (BVS I), conducted
in 2000, 3072 participants (1350 men, 1722 women) of the general
population of the city of Bonn and two rural townships, aged 18 to 79 years,
took part. Participants were selected by simple random sampling from the
registries of residents. In this follow-up study 6.6 years later, the same
population was investigated again to identify the incidence of newly devel-
oped CVD and of progression of pre-existing CVD.
Methods: From May 2007 to September 2008, we contacted all BSV
I participants and invited them for a reinvestigation. The participants an-
swered a standardized questionnaire and were examined by clinical means
and by duplex ultrasound imaging in the same way as in BVS I.
Results: The response at follow-up after 6.6 years was 84.6%. We
reinvestigated 1978 participants. The prevalence for varicose veins rose from
22.7% to 25.1% and for chronic venous insufficiency (CVI) from 14.5% to
16%. The incidence for new varicose veins was 13.7% and for newCVI 13.0%
per 6.6 years, increasing with age. Participants with CEAP class C2 as a
maximum at BVS I increased to higher C classes in 19.8% (nonsaphenous
varicose veins) and in 31.8% (saphenous varicose veins).
Conclusions: These results show a high incidence of about 2% for
varicose veins and for CVI per year. During the same time, the incidence of
progression to higher C classes seems to be very high.
Prolonged Mechanical Stretch is Associated with Upregulation of
Hypoxia-inducible Factors and Reduced Contraction in Rat Inferior
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Background: Decreased venous tone and vein wall dilation secondary
to venous hypertension may contribute to varicose vein formation. We have
shown that prolonged increases in vein wall tension are associated with
overexpression of matrix metalloproteinases (MMPs) and increased venous
relaxation. Expression of hypoxia-inducible factors (HIFs) also increases
with mechanical stretch. This study assessed whether upregulation of HIF is
an intermediary mechanism linking the prolonged increases in vein wall
tension to the changes in venous contraction and MMP expression.
Methods: Circular segments of inferior vena cava (IVC) from male
Sprague-Dawley rats were suspended between two wires in a tissue bath.
IVC segments were subjected to control 0.5g basal tension for 1 hour. After
eliciting a control contraction to KCl (96mM) and phenylephrine (PHE,
10-5M), the veins were exposed to prolonged 18 hours of basal tension at
0.5g, 2g, 2g plus HIF inhibitor (U-0126 10-5M, 17-DMAG 10-5M, echi-
nomycin 10-6M), or 2g plus dimethyloxallyl glycine (10-4M), a prolyl-
hydroxylase inhibitor that stabilizes HIF. The fold-change in contraction to
KCl or PHE after prolonged tension for 18 hours was compared with the
corresponding initial contraction at 0.5g tension for 1 hour. Vein homoge-
nates were analyzed for HIF-1, HIF-2, MMP-2, and MMP-9 expression
using real-time reverse transcription polymerase chain reaction.
Results: Compared with control IVC contraction at 0.5g tension for 1
hour, the contraction to KCl and PHE at prolonged 0.5g tension for 18
hours was 1.1 0.06 and 2.0 0.35, respectively. KCl- and PHE-induced
contraction at prolonged 2g tension was significantly reduced (0.72 0.05
and 0.87  0.13, respectively). KCl-induced contraction was restored in
IVC exposed to prolonged 2g tension plus the HIF inhibitor U0126
(1.14 0.05) or echinomycin (1.11 0.15). U0126 and echinomycin also
restored PHE-induced IVC contraction after prolonged 2g tension (1.38
0.15 and 1.99  0.40, respectively). Stabilization of HIF using DMOG
further reduced KCl and PHE-induced contraction in veins under pro-
longed 2g tension (0.57 0.01 and 0.47 0.06, respectively), implicating
HIF in the reduced contraction associated with prolonged stretch. HIF-1
and HIF-2 messenger RNA expression was increased in IVC segments
under prolonged 2g tension, and reversed in IVC treated with U0126,
17-DMAG, or echinomycin. The overexpression of HIF was associated with
increased MMP-2 and MMP-9 mRNA expression.
Conclusions: Prolonged increases in vein wall tension are associated
with overexpression of HIF-1 andHIF-2 in rat IVC. The upregulation of
HIF is associated with increased MMP-2 and MMP-9 expression and
reduced venous contraction. The data suggest that the increased vein wall
tension secondary to venous hypertension may induce HIF overexpression
and cause an increase in MMPs expression and reduction of venous contrac-
tion, leading to progressive venous dilation and varicose vein formation.
Ca2-Dependent Venous Contraction by the Saponoside Escin in Rat
Inferior Vena Cava: Implications in Venotonic Treatment of Varicose Veins
J. D. Raffetto, and R. A. Khalil, Boston, Mass
From Brigham and Women’s Hospital.
Background: Saponosides such as horse chestnut seed extract (escin)
exhibit venotonic properties that have been used in the treatment of varicose
veins. Escin is known to form pores in the cell membrane, but the cellular
mechanisms underlying its venotonic properties and long-term effects on
venous function are unclear. Because Ca2 is a major regulator of venous
smooth muscle function, we tested the hypothesis that escin promotes
Ca2-dependent mechanisms of venous contraction.
Methods: Circular segments of inferior vena cava (IVC) were isolated
frommale Sprague-Dawley rats and suspended between two wires in a tissue
bath filled with Krebs solution for measurement of isometric contraction.
After control contraction to 96mM KCl, the effect of increasing concentra-
tions of escin (10-10 to 10-4M) on venous contraction wasmeasured. To test
for Ca2-independent effects, the response to increasing concentrations of
escin was measured in Ca2-free (2mM ethyleneglycotetraacetic acid)
Krebs. To test for Ca2-dependent effects, IVC segments pretreated with
escin (10-4 M) were incubated in 0 Ca2 Krebs for 5 minutes, then
increasing extracellular CaCl2 concentrations (0.1, 0.3, 0.6, 1, 2.5mM)were
added and the [Ca2]e-contraction relationship was constructed. Contrac-
tion data were presented as mg/mg tissue (means  standard error of the
mean).
Results: In IVC, the -adrenergic agonist phenylephrine (PHE, 10-5
M) and membrane depolarization by 96mMKCl caused significant contrac-
tion (175.4  21.1 and 216.5  24.2, respectively). In normal Krebs
(2.5mM Ca2), escin caused concentration-dependent contraction, reach-
ing a maximum of 115.7  15.3 at 10-4 M. The escin-induced contraction
was reversible. After being washed three times with Krebs, the veins returned
to a relaxed state, suggesting that the escin-induced contraction is not a rigor
state. In Ca2-free Krebs, there was essentially no contraction in response to
increasing concentrations of escin (1.9  1.9 at 10-4M), supporting that
escin-induced contraction is not solely due to its pore-forming properties,
potential loss of intracellular adenosine triphosphate, and consequent con-
tractile rigor. In escin-treated veins incubated in 0 Ca2 Krebs, stepwise
addition of extracellular CaCl2 caused corresponding increases in contrac-
tion that reached a maximum of 76.9  15.3 at 2.5mM CaCl2. In IVC
segments pretreated with escin (10-4M) for 2 hours, PHE caused a small
contraction (5.8  3.6, P  .001), and KCl-induced contraction was
significantly reduced (82.3  14.8, P  .026).
Conclusions: In rat IVC, escin induces extracellular Ca2-dependent
contraction that could translate into measurable venotonic effects. How-
ever, escin also disrupts -adrenergic receptor-mediated pathways and de-
polarization-induced Ca2 entry-dependent vein contraction. Thus the
initial venotonic benefits of escin may be offset by long-term disruption of
venous smooth muscle response to vasoactive stimuli and thereby limit its
long-term therapeutic benefit in varicose veins.
Neither Ascending nor Descending Theory Can Fully Explain the Pattern
of Venous Reflux in Patients with Primary Chronic Venous Disease
M. I. Qureshi, A. MacDonald, L. Wing, C. S. Lim, M. Ellis, I. J. Franklin,
and A. H. Davies, London, United Kingdom
From Imperial College London.
Background: The natural history of venous reflux in patients with
chronic venous disease (CVD) remains unclear. This study assessed the
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